Laboratorio Farmaceutico Erfo SpA (IT:ERFO) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Laboratorio Farmaceutico Erfo S.p.A., listed on Euronext Growth Milan, has acquired 4,000 shares as part of its ongoing buyback plan, representing 0.04% of its share capital. This latest purchase brings their total treasury shares to 5.44% of the share capital. The company continues to focus on expanding its business lines and enhancing its nutraceutical offerings.
For further insights into IT:ERFO stock, check out TipRanks’ Stock Analysis page.